A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Recruiting · NCT06146257 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2026-04-13 | NCT06146257 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GluBio Therapeutics Inc. | 1 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alliance for Multispecialty Research, LLC | Merriam | United States | 1 |
| City of Hope Medical Center | Duarte | United States | 313 |
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |
| Memorial Sloan Kettering Cancer Center-David H. Koch Center | New York | United States | 1 |
| Roswell Park Comprehensive Cancer Center | Buffalo | United States | 63 |
| University of California Irvine | Irvine | United States | 30 |
| University of Kansas Medical Center Research Institute, Inc. | Kansas City | United States | 9 |
| University of Texas M. D. Anderson Cancer Center | Houston | United States | 6 |